Background
Methods
Study design and population
Data collection
The population survey
Medical record review
Statistical analysis
Results
Characteristic | Participants (n = 4059) |
---|---|
Gender | |
Female | 2300 (56.7) |
Male | 1759 (43.3) |
Age (years) | |
45–54 | 770 (19.0) |
55–64 | 1136 (28.0) |
65–74 | 1225 (30.2) |
75 and above | 928 (22.8) |
aEmployment status | |
Employed | 1105 (27.9) |
Unemployed | 596 (15.1) |
Retired | 2253 (57.0) |
aBMI (kg/m2) | |
Not overweight (< 25.0) | 1161 (29.6) |
Overweight (25.0–29.9) | 1583 (40.3) |
Obese (≥30.0) | 1184 (30.1) |
No. of pain sites | |
Single site | 777 (19.1) |
Multi-site | 3282 (80.9) |
Morbidity burden (BNF drug count) | |
< 10 count | 2222 (54.7) |
≥ 10 count | 1837 (45.3) |
SF12 - Physical health, mean (SD) | 43.6 (12.4) |
SF12 - Mental health, mean (SD) | 49.5 (10.5) |
OA diagnosis | |
Yes | 502 (12.4) |
No | 3557 (87.6) |
Total (n = 4059) | 45-54y n (%) | 55-64y n (%) | 65-74y n (%) | ≥75y n (%) | ||
---|---|---|---|---|---|---|
n | % (95% CI) | |||||
Core treatments | ||||||
***Written informationa | 934 | 23.0 (21.7,24.3) | 190 (24.7) | 298 (26.2) | 267 (21.8) | 179 (19.3) |
**Muscle strengthening exercises | 532 | 13.1 (12.1,14.1) | 113 (14.7) | 172 (15.1) | 150 (12.2) | 97 (10.5) |
*Aerobic fitness exercise | 154 | 3.8 (3.2,4.4) | 36 (4.7) | 44 (3.9) | 55 (4.5) | 19 (2.0) |
Dieting to lose weightb | 261 | 9.4 (8.3,10.5) | 37 (7.1) | 90 (10.9) | 99 (11.4) | 35 (6.4) |
1st and 2nd line pharmacological treatment | ||||||
***Paracetamol | 1270 | 31.3 (29.9,32.7) | 149 (19.4) | 283 (24.9) | 395 (32.2) | 443 (47.7) |
***Anti-inflammatory creams/gels e.g. topical NSAIDs | 1055 | 26.0 (24.7,27.4) | 150 (19.5) | 243 (21.4) | 341 (27.8) | 321 (34.6) |
*Capsaicin cream | 66 | 1.6 (1.2,2.0) | 4 (0.5) | 22 (1.9) | 21 (1.7) | 19 (2.0) |
***Anti-inflammatory tablets e.g. oral NSAIDs | 1276 | 31.4 (30.0,32.8) | 306 (39.7) | 406 (35.7) | 366 (29.9) | 198 (21.3) |
***Stronger painkillers e.g. opioids, compound analgesics | 1641 | 40.4 (38.9,41.9) | 263 (34.2) | 416 (36.6) | 535 (43.7) | 427 (46.0) |
Intra-articular corticosteroid injection | 463 | 11.4 (10.4,12.4) | 81 (10.5) | 146 (12.9) | 131 (10.7) | 105 (11.3) |
Adjunctive treatment | ||||||
Warmth, heat or cold application | 334 | 8.2 (7.4,9.0) | 57 (7.4) | 105 (9.2) | 95 (7.8) | 77 (8.3) |
***Walking aids | 676 | 16.7 (15.6,17.8) | 64 (8.3) | 122 (10.7) | 179 (14.6) | 311 (33.5) |
***Assistive devices | 301 | 7.4 (6.6,8.2) | 24 (3.1) | 44 (3.9) | 75 (6.1) | 158 (17.0) |
Transcutaneous electric nerve stimulation (TENS) | 127 | 3.1 (2.6,3.6) | 22 (2.9) | 41 (3.6) | 37 (3.0) | 27 (2.9) |
Shock-absorbing shoes or insoles | 247 | 6.1 (5.4,6.8) | 41 (5.3) | 63 (5.5) | 81 (6.6) | 62 (6.7) |
Appliances and support and braces | 265 | 6.5 (5.7,7.3) | 52 (6.8) | 80 (7.0) | 59 (4.8) | 74 (8.0) |
Service use | ||||||
Joint arthroplasty/operation | 365 | 9.0 (8.1,9.9) | 73 (9.5) | 105 (9.2) | 102 (8.3) | 85 (9.2) |
***Manual therapy | 998 | 24.6 (23.3,25.9) | 219 (28.4) | 311 (27.4) | 282 (23.0) | 186 (20.0) |
Characteristic | aWritten information | Muscle strengthening/ aerobic fitness exercise | bDieting to lose weight | Paracetamol | Topical NSAIDs | |||||
---|---|---|---|---|---|---|---|---|---|---|
n (%) | AOR (95% CI) | n (%) | AOR (95% CI) | n (%) | AOR (95% CI) | n (%) | AOR (95% CI) | n (%) | AOR (95% CI) | |
Total | 934 | 618 | 261 | 1270 | 1055 | |||||
Gender | ||||||||||
Male | 353 (20.1) | 1 | 244 (13.9) | 1 | 92 (7.1) | 1 | 511 (29.1) | 1 | 424 (24.1) | 1 |
Female | 581 (25.3) | 1.28×× (1.09, 1.50) | 374 (16.3) | 1.12 (0.93, 1.35) | 169 (11.5) | 1.54×× (1.16, 2.04) | 759 (33.0) | 1.09 (0.94, 1.27) | 631 (27.4) | 1.13 (0.97, 1.32) |
Age group (years) | ||||||||||
45–54 | 190 (24.7) | 1 | 133 (17.3) | 1 | 37 (7.1) | 1 | 149 (19.4) | 1 | 150 (19.5) | 1 |
55–64 | 298 (26.2) | 1.02 (0.80, 1.29) | 192 (16.9) | 0.78 (0.60, 1.03) | 90 (10.9) | 1.52 (0.97, 2.36) | 283 (25.0) | 1.12 (0.87, 1.45) | 243 (21.4) | 0.96 (0.74, 1.24) |
65–74 | 267 (21.8) | 0.76 (0.56, 1.03) | 183 (14.9) | 0.55×× (0.38, 0.78) | 99 (11.4) | 1.64 (0.94, 2.86) | 395 (32.2) | 1.29 (0.94, 1.76) | 341 (27.8) | 1.20 (0.88, 1.64) |
≥ 75 | 179 (19.3) | 0.56×× (0.40, 0.79) | 110 (11.9) | 0.37××× (0.25, 0.55) | 35 (6.4) | 0.74 (0.39, 1.40) | 443 (47.7) | 1.91××× (1.38, 2.65) | 321 (34.6) | 1.32 (0.94, 1.84) |
Employment status | ||||||||||
Employed | 277 (25.1) | 1 | 171 (15.5) | 1 | 56 (7.1) | 1 | 203 (18.4) | 1 | 197 (17.8) | 1 |
Unemployed | 143 (24.0) | 0.74× (0.58, 0.98) | 102 (17.1) | 1.03 (0.77, 1.38) | 49 (12.8) | 1.06 (0.67, 1.66) | 195 (32.7) | 1.16 (0.90, 1.51) | 157 (26.3) | 1.17 (0.90, 1.52) |
Retired | 494 (21.9) | 0.91 (0.71, 1.18) | 327 (14.5) | 1.17 (0.87, 1.58) | 149 (9.7) | 0.92 (0.58, 1.45) | 841 (37.3) | 1.15 (0.89, 1.50) | 667 (29.6) | 1.12 (0.86, 1.46) |
No. of pain sites | ||||||||||
Single site | 116 (14.9) | 1 | 106 (13.6) | 1 | 31 (6.4) | 1 | 180 (23.2) | 1 | 151 (19.4) | 1 |
Multi-site | 818 (24.9) | 1.59××× (1.26, 2.00) | 512 (15.6) | 0.98 (0.77, 1.26) | 230 (10.1) | 1.08 (0.70, 1.68) | 1090 (33.2) | 1.10 (0.88, 1.35) | 904 (27.5) | 1.15 (0.93, 1.43) |
Morbidity burden (BNF drug count) | ||||||||||
< 10 counts | 501 (22.5) | 1 | 294 (13.2) | 1 | 87 (5.9) | 1 | 451 (20.3) | 1 | 419 (18.9) | 1 |
≥ 10 counts | 433 (23.6) | 0.91 (0.75, 1.08) | 324 (17.6) | 1.44×× (1.16, 1.77) | 174 (13.5) | 1.87××× (1.37, 2.57) | 819 (44.6) | 1.88×××(1.60, 2.23) | 636 (34.6) | 1.61××× (1.35, 1.91) |
BMI (Kg/m2) | ||||||||||
Not overweight (< 25.0) | 253 (21.8) | 1 | 170 (14.6) | 1 | n/a | n/a | 343 (29.5) | 1 | 287 (24.7) | 1 |
Overweight (25.0–29.9) | 355 (22.4) | 1.01 (0.83, 1.23) | 246 (15.5) | 1.02 (0.82, 1.27) | 84 (5.3) | 1 | 482 (30.4) | 1.05 (0.87, 1.27) | 420 (26.5) | 1.12 (0.93, 1.35) |
Obese (≥30.0) | 295 (24.9) | 0.96 (0.78, 1.18) | 180 (15.2) | 0.80 (0.63, 1.02) | 177 (15.0) | 2.48××× (1.85, 3.32) | 388 (32.8) | 0.95 (0.78, 1.16) | 311 (26.3) | 0.91 (0.74, 1.12) |
SF12 – Physical health (Quartile) | ||||||||||
Worst to 27.58 | 273 (27.7) | 2.13××× (1.63, 2.77) | 168 (17.0) | 1.64×× (1.20, 2.24) | 102 (14.2) | 1.44 (0.89, 2.32) | 467 (47.4) | 2.64××× (2.04, 3.41) | 344 (34.9) | 1.67 × × × (1.28, 2.16) |
27.59–38.36 | 249 (25.4) | 1.76××× (1.38, 2.25) | 167 (17.0) | 1.67 ×××(1.26, 2.23) | 75 (11.0) | 1.29 (0.81, 2.05) | 361 (36.8) | 2.24××× (1.75, 2.87) | 290 (29.6) | 1.60 × × × (1.25, 2.04) |
38.37–48.26 | 231 (23.1) | 1.53××× (1.21, 1.93) | 155 (15.5) | 1.47×× (1.12, 1.93) | 42 (6.2) | 0.86 (0.53, 1.40) | 261 (26.1) | 1.70××× (1.33, 2.16) | 225 (22.5) | 1.26 (0.99, 1.61) |
48.27–71.88 | 166 (16.9) | 1 | 115 (11.7) | 1 | 34 (5.5) | 1 | 139 (14.1) | 1 | 156 (15.8) | 1 |
SF12 – Mental health (Quartile) | ||||||||||
Worst to 39.93 | 275 (28.5) | 1.42×× (1.12, 1.78) | 176 (18.2) | 1.11 (0.85, 1.44) | 100 (14.0) | 1.90×× (1.26, 2.84) | 404 (41.9) | 1.59××× (1.28, 1.97) | 314 (32.5) | 1.51××× (1.21, 1.89) |
39.94–49.55 | 231 (23.5) | 1.18 (0.95, 1.48) | 140 (14.3) | 0.97 (0.75, 1.26) | 68 (10.6) | 1.64×(1.08, 2.48) | 337 (34.3) | 1.34×× (1.08, 1.65) | 290 (29.5) | 1.48××× (1.18, 1.84) |
49.56–57.11 | 207 (21.4) | 1.14 (0.91, 1.43) | 144 (14.9) | 1.04 (0.80, 1.35) | 43 (6.9) | 1.10 (0.70, 1.74) | 233 (24.1) | 1.04 (0.84, 1.30) | 203 (21.0) | 1.09 (0.87, 1.37) |
57.12 to 74.46 | 206 (19.8) | 1 | 145 (14.0) | 1 | 42 (5.8) | 1 | 254 (24.5) | 1 | 208 (20.0) | 1 |
OA diagnosis | ||||||||||
Yes | 146 (29.1) | 1.57××× (1.26, 1.96) | 88 (17.5) | 1.31× (1.00, 1.70) | 31 (8.9) | 0.79 (0.52, 1.21) | 203 (40.4) | 1.30× (1.05, 1.62) | 166 (33.1) | 1.30× (1.04, 1.62) |
No | 788 (22.2) | 1 | 530 (14.9) | 1 | 230 (9.5) | 1 | 1067 (30.0) | 1 | 889 (25.0) | 1 |